Provectus Biopharmaceuticals is investigating new therapies for the treatment of skin cancer, liver cancer and breast cancer. Provectus’ investigational oncology drug, PV-10, is an ablative immunotherapy under investigation in solid tumor cancers.
University of Tennessee, Knoxville, Neyland Greenway, Knoxville Central Business District, Fort Sanders, Knoxville, Knox County, East Tennessee, Tennessee, 37996, United States
